Bio Rad Laboratories Stock Beneish M Score

BIO Stock  USD 275.94  0.34  0.12%   
This module uses fundamental data of Bio Rad to approximate the value of its Beneish M Score. Bio Rad M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Bio Rad Piotroski F Score and Bio Rad Altman Z Score analysis.
  
At this time, Bio Rad's Short and Long Term Debt Total is very stable compared to the past year. As of the 27th of April 2024, Net Debt is likely to grow to about 1.1 B, while Short Term Debt is likely to drop about 30.8 M. At this time, Bio Rad's Stock Based Compensation To Revenue is very stable compared to the past year. As of the 27th of April 2024, PB Ratio is likely to grow to 2.15, while Invested Capital is likely to drop 0.13.
At this time, it appears that Bio Rad Laboratories is an unlikely manipulator. The earnings manipulation may begin if Bio Rad's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Bio Rad executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Bio Rad's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.75
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

1.06

Focus
Asset Quality

1.02

Focus
Expense Coverage

1.1

Focus
Gross Margin Strengs

1.18

Focus
Accruals Factor

1.1

Focus
Depreciation Resistance

0.71

Focus
Net Sales Growth

0.52

Focus
Financial Leverage Condition

0.87

Focus

Bio Rad Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Bio Rad's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables272.8 M500.9 M
Way Down
Slightly volatile
Total Revenue1.4 B2.7 B
Way Down
Slightly volatile
Total Assets12.9 B12.3 B
Sufficiently Up
Slightly volatile
Total Current Assets3.2 BB
Sufficiently Up
Slightly volatile
Non Current Assets Total9.7 B9.3 B
Sufficiently Up
Slightly volatile
Property Plant Equipment371.9 M573.4 M
Way Down
Slightly volatile
Depreciation And Amortization202 M192.4 M
Sufficiently Up
Slightly volatile
Selling General Administrative481.6 M846.8 M
Way Down
Slightly volatile
Total Current Liabilities338.4 M522.8 M
Way Down
Slightly volatile
Non Current Liabilities Total3.2 BB
Sufficiently Up
Slightly volatile
Short Term Debt30.8 M41.4 M
Way Down
Pretty Stable
Long Term Debt1.3 B1.2 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities393.7 M374.9 M
Sufficiently Up
Slightly volatile
Short Term Investments1.3 B1.2 B
Sufficiently Up
Slightly volatile
Long Term Investments5.1 B7.7 B
Way Down
Slightly volatile
Gross Profit Margin0.630.5358
Fairly Up
Pretty Stable

Bio Rad Laboratories Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Bio Rad's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Bio Rad in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Bio Rad's degree of accounting gimmicks and manipulations.

About Bio Rad Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Other Operating Expenses

1.22 Billion

At this time, Bio Rad's Other Operating Expenses is very stable compared to the past year.

Bio Rad Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Bio Rad. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables392.7M419.4M423.5M494.6M500.9M272.8M
Total Revenue2.3B2.5B2.9B2.8B2.7B1.4B
Total Assets8.0B13.0B17.8B13.5B12.3B12.9B
Total Current Assets2.2B2.1B2.0B3.2B3.0B3.2B
Net Debt(220.9M)(648.1M)(459.8M)764.0M1.0B1.1B
Short Term Debt426.2M1.8M489K465K41.4M30.8M
Long Term Debt13.6M12.3M10.5M1.2B1.2B1.3B
Operating Income229.7M411.0M489.4M482.6M383.8M403.0M
Investments(119.3M)119.6M(538.2M)(994.2M)(110.5M)(116.1M)

Bio Rad ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bio Rad's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Rad's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

About Bio Rad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

  0.7ELYM Eliem Therapeutics Upward RallyPairCorr
  0.64ACB Aurora Cannabis Sell-off TrendPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Bio Rad Piotroski F Score and Bio Rad Altman Z Score analysis.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.81)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.